FORTRESS BIOTECH INC (FBIO) Stock Cash Flow
NASDAQ:FBIO - Nasdaq - US34960Q3074 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -123.52M | -154.15M | -213.91M | -164.83M | -102.99M | |||
| Depreciation Amortization | 4.54M | 6.00M | 7.39M | 5.10M | 3.70M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -20.54M | -12.52M | -720.00K | 36.37M | -4.78M | |||
| Interest Paid | 6.76M | 7.95M | 9.42M | 6.92M | 8.82M | |||
| Taxes Paid | 80.00K | -55.00K | 860.00K | 990.00K | N/A | |||
| Other non cash items | 37.32M | 32.45M | 27.84M | 6.81M | 20.38M | |||
| OPERATING CASH FLOW | -102.22M | -128.22M | -179.40M | -116.54M | -83.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -5.06M | -2.72M | -4.97M | -3.13M | |||
| Other Investing Activity | 4.97M | 2.96M | -20.21M | 45.48M | -4.04M | |||
| INVESTING CASH FLOW | -63.00K | -2.10M | -22.93M | 40.51M | -7.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.66M | -39.79M | 44.25M | -6.19M | -29.67M | |||
| Stock Issued/Repurchased | 118.95M | 76.71M | 25.70M | 44.73M | 167.36M | |||
| Dividend Paid | -6.73M | -8.77M | -8.78M | -8.78M | -6.75M | |||
| Other Financing Activity | -25.43M | 4.59M | 14.16M | 119.23M | 41.47M | |||
| FINANCING CASH FLOW | 88.45M | 32.74M | 75.32M | 148.99M | 172.41M | |||
| CHANGE IN CASH | -13.83M | -97.59M | -127.01M | 72.96M | 81.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -102.22M | -128.22M | -179.40M | -116.54M | -83.68M | |||
| Capital Expenditure | N/A | -5.06M | -2.72M | -4.97M | -3.13M | |||
| FREE CASH FLOW | -107.24M | -133.29M | -182.12M | -121.51M | -86.81M | |||
All data in USD